Cardiovascular Ultrasound Market

Cardiovascular Ultrasound Market Size (2024 to 2029)

The cardiovascular ultrasound market size was valued at USD 1.44 Billion in 2024 and is expected to reach USD 1.88 Billion by 2029. The market size is projected to grow at a CAGR of 5.41% during the forecast period 2024 to 2029.

MARKET DRIVERS

The market for cardiovascular ultrasound is expected to grow as cardiovascular disorders like heart attacks become more prevalent.  This will increase demand for cardiovascular ultrasound as it uses sound waves to produce images of the heart. This is expected to drive the market growth of the cardiovascular ultrasound market. According to the World Health Organization's June 2021 update, cardiovascular diseases are the leading cause of death worldwide.  Around three-quarters of CVD-related deaths are reported in low- and middle-income countries, so the market for cardiovascular ultrasound systems is expected to grow due to the high mortality rate associated with CVDs.

The market's growth rate will be increased during the forecast period because of consumers' growing demand for non-invasive diagnostic techniques. The market for cardiovascular ultrasound is being fuelled by the growing acceptance of non-invasive diagnostic techniques. Increasing the use of preventive medications will also slow the market's growth rate. Furthermore, the rising focus of manufacturers operating to develop innovative and novel cardiovascular ultrasound systems will be a major factor influencing the growth of the cardiovascular ultrasound system market.

The market factors that will most contribute to the growth of the cardiovascular ultrasound system market are the rise in changing lifestyles and rising spending on healthcare infrastructure. The increase in the geriatric population and an increase in the number of governments promoting awareness are other factors fueling the growth of the cardiovascular ultrasound system market.

MARKET RESTRAINTS

The strict regulatory practices concerning the commercialization of ultrasound devices limit market growth. The regulatory policies and approval procedures for ultrasound devices vary across different countries. This leads to delays in product launches in different geographic locations. For instance, the Indian government ensures the quality of devices before they are marketed. Governments also focus on monitoring these devices, thereby controlling device-related problems.

The cardiovascular ultrasound system market's growth rate will be restricted by the high cost of the associated equipment. An unfavorable reimbursement scenario will also function as a significant market restraint and slow the market's growth rate. Additionally, the market for cardiovascular ultrasound systems would face difficulties due to a lack of qualified and experienced ultrasound technicians in developing countries. Additionally, the financial consequences of implementing new technology will limit and further decrease the market's rate of expansion.

Impact of COVID-19 on the Cardiovascular Ultrasound Market

Cardiac ultrasound is also known as echocardiography. This is a non-invasive diagnostic technique that can provide detailed hemodynamic information in a short period at a patient's bedside. It is a rapid, inexpensive application that speeds up the diagnosis and management of life-threatening diseases, such as acute coronary syndrome, cardiomyopathy, pulmonary embolism, and Stanford type A aortic dissection. Cardiac ultrasound can also differentiate shock states and guide faster measures. It uses ultrasonic waves that bounce off the heart to create a moving image of it. It lets physicians view the heart in motion, including the beating activity. Cardiovascular ultrasound allows physicians to view the heart’s anatomy from many different angles and observe the heart rhythm. It is the most effective way to visualize the function and movement of the heart and cardiac muscle valves.

Covid-19 has a significant impact on various healthcare facilities. On the cardiovascular ultrasound market, COVID-19 had a detrimental effect. This is because non-urgent medical procedures, such as cardiovascular ultrasound exams, have decreased due to the epidemic. Numerous healthcare services, including elective operations, encountered disruptions during the pandemic. As a result, fewer cardiovascular ultrasonography operations were carried out. This has an impact on the market expansion for cardiovascular ultrasonography. Additionally due to lockdowns, traveling restrictions, and concerns regarding potential exposure to the virus. Many individuals postponed routine screenings and follow-up visits including cardiovascular ultrasound examinations. This led to a decrease in the growth of cardiovascular ultrasound.

Report Coverage

Global Cardiovascular Ultrasound Market Analysis By Test Type

In 2024, the transthoracic echocardiography market sector displayed dominance. In 2024, the category was responsible for almost 55% of total revenue. This is because new products have recently entered the market. A robust CAGR is anticipated for this market segment during the forecasted period. Transthoracic echocardiograms produce an image of the heart by penetrating skin and other tissues with ultrasound waves. During the projection period, the sector for stress echocardiograms is anticipated to increase at the fastest rate. The benefits of stress echocardiography, which can provide information on cardiac muscles and valves before and after the load on heart muscles, are credited with this rise.

Global Cardiovascular Ultrasound Market Analysis By Technology

Among these, the Doppler segment has shown its dominance in the past years. The Doppler Imaging Technology provides sharp images in a shorter time and the segment accounted for the maximum revenue share of over 42.5% in 2024. The technique is increasing its prominence in developing countries, such as India and China, due to the increasing penetration of technologically advanced systems in these countries. Doppler echocardiography helps measure blood flow within the heart without using any invasive methods. In addition, workshops conducted for Doppler echocardiography are expected to boost its adoption. The 3D/4D technology segment is the second largest. It helps to identify the actual site or valve with cardiac infection.

Global Cardiovascular Ultrasound Market Analysis By Device Display

The color systems segment accounted for the highest revenue share of more than 88% in 2024. This is because color systems are mostly preferred over B/W due to the clarity of images offered by these systems. In addition, color cardiovascular ultrasound helps in better diagnosis. Hitachi has a series of color systems, which are available across the globe. B/W display technology is generally the most cost-effective compared to color display. This can be advantageous to healthcare facilities, especially in resource-constrained settings. It allows for a more accessible and affordable cardiac ultrasound system without compromising essential image quality.

Global Cardiovascular Ultrasound Market Analysis By End User

Among these, the Hospital segment accounted for the highest revenue share of more than 45.8% in 2024. This is due to an increase in healthcare expenditure and an increasing number of cardiovascular patients across the globe. Ultrasound systems are generally used in hospitals for non-invasive imaging of the heart.

REGIONAL ANALYSIS 

Regionally, North America dominates the cardiovascular ultrasound market. This is due to the expanding usage of preventive medicine and modern technology. The market’s growth rate in this region will also be boosted by improved infrastructure in healthcare amenities. North America dominated the global market and accounted for a revenue share of 29.1% in 2024. This is attributed to cardiovascular disease which is one of the leading causes of death in the region, with conditions such as coronary artery disease, hypertension, and heart failure affecting a significant proportion of the population. This has led to a greater demand for diagnostic tools, such as cardiovascular ultrasound, to assess and monitor cardiovascular health.

Europe is the second largest segment regionally in the cardiovascular ultrasound market. This is because of the support of several professional organizations which are helping the growth of this segment in the market. The medical imaging industry in the U.K. has a favorable environment for research and development due to the government and private industry’s investment support. According to British Heart Foundation, more than 25% of deaths occur due to cardiovascular disorders. The increasing prevalence of these diseases and the increasing demand for effective management drives the cardiovascular ultrasound market.

The Asia Pacific region is expected to grow at the fastest CAGR, due to developments in technology which resulted in more accurate, efficient, and accessible cardiovascular ultrasound machines. Additionally, economic growth in the region has led to an expansion of the middle class and increased healthcare spending. This has led to greater demand for advanced medical technologies, including cardiovascular ultrasound.

KEY PLAYERS IN THE GLOBAL CARDIOVASCULAR ULTRASOUND MARKET

Some market players in the breast imaging market include GE Healthcare, Koninklijke Philips, Siemens Healthineers AG, Hitachi Medical Corp., Samsung Medison Co. Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray), Chison Wuxi Xiangsheng Medical Technology Co., Ltd., Fujifilm Sonosite, Inc.

RECENT HAPPENINGS IN THE MARKET

• New release of Philips Echo Navigator helps interventional teams treat structural heart disease with greater ease and efficiency

• FUJIFILM Visual Sonics Launches the New Multi-modal Vevo F2 Imaging Platform for Preclinical Ultrasound

DETAILED SEGMENTATION OF THE GLOBAL CARDIOVASCULAR ULTRASOUND MARKET INCLUDED IN THIS REPORT

This research report on the cardiovascular ultrasound market has been segmented and sub-segmented based on the test type, technology, Device display, End-User, and region.

By Test Type

• Transthoracic Echocardiography
• Transoesophageal Echocardiography
• Fetal Echocardiography
• Stress Echocardiography​​​​​​​

By Technology

• 2D Ultrasound
• 3D and 4D Ultrasound
• Doppler Imaging​​​​​​​

By Device Display

• Colour Display
• Black and white display​​​​​​​

By End User

• Hospitals
• Cardiology Centres
• Ambulatory Centres
• Other end users (Research Institutes, Medical Device, and pharmaceutical companies)​​​​​​​

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)